Sivik Global Healthcare LLC Boosts Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Sivik Global Healthcare LLC lifted its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 25.0% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,000 shares of the company's stock after purchasing an additional 5,000 shares during the quarter. HCA Healthcare comprises approximately 4.7% of Sivik Global Healthcare LLC's holdings, making the stock its 4th largest position. Sivik Global Healthcare LLC's holdings in HCA Healthcare were worth $8,639,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Atwood & Palmer Inc. bought a new stake in shares of HCA Healthcare in the 1st quarter worth approximately $28,000. Whipplewood Advisors LLC purchased a new position in HCA Healthcare in the 4th quarter worth approximately $31,000. ORG Partners LLC raised its holdings in HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after acquiring an additional 86 shares during the last quarter. Tidemark LLC purchased a new position in HCA Healthcare in the 4th quarter worth approximately $36,000. Finally, Legacy Investment Solutions LLC raised its holdings in HCA Healthcare by 99.0% in the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after acquiring an additional 95 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Up 0.1%

Shares of HCA Healthcare stock opened at $377.26 on Friday. The company has a fifty day moving average of $362.30 and a 200 day moving average of $334.77. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a market capitalization of $90.76 billion, a P/E ratio of 16.77, a P/E/G ratio of 1.30 and a beta of 1.49. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The business had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. During the same quarter in the prior year, the firm earned $5.36 EPS. The business's revenue was up 5.7% on a year-over-year basis. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare's payout ratio is 12.81%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer now owns 12,646 shares of the company's stock, valued at $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on HCA. Morgan Stanley set a $410.00 target price on shares of HCA Healthcare and gave the company an "equal weight" rating in a research note on Monday, June 9th. Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Monday, April 28th. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Finally, Guggenheim assumed coverage on HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. Seven equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $392.47.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.